[Federal Register Volume 84, Number 29 (Tuesday, February 12, 2019)]
[Notices]
[Pages 3455-3456]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01958]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2019-0002]


Advisory Committee on Immunization Practices (ACIP); Correction

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting with comment period; correction.

-----------------------------------------------------------------------

SUMMARY: On January 28, 2019, the Centers for Disease Control and 
Prevention (CDC) in the Department of Health and Human Services (HHS) 
published a notice announcing the next meeting of the Advisory 
Committee on Immunization Practices on February 27-28, 2019 in Atlanta, 
GA. The notice did not include the docket number for public comment or 
instructions for submitting public comment. This notice provides that 
information for the public.

DATES: The meeting will be held on February 27-28, 2019 at the CDC Tom 
Harkin Global Communication Center, Centers for Disease Control and

[[Page 3456]]

Prevention Headquarters (Building 19), Room 232, 1600 Clifton Road NE, 
Atlanta, GA 30329. Written comments must be received on or before March 
2, 2019.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0002 by any of the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: Centers for Disease Control and Prevention, 1600 
Clifton Rd. NE, Mailstop A-27, Atlanta, GA 30329-4027.
    Instructions: All submissions received must include the agency name 
and Docket Number.
    Instructions: All relevant comments received will be posted without 
change to http://regulations.gov, including any personal information 
provided. For access to the docket to read background documents or 
comments received, go to http://www.regulations.gov.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee 
Management Specialist, National Center for Immunization and Respiratory 
Diseases, Centers for Disease Control and Prevention, telephone 404-
639-8836, email [email protected].

SUPPLEMENTARY INFORMATION: In accordance with the Federal Advisory 
Committee Act, the Centers for Disease Control and Prevention (CDC), 
announces the following meeting of the Advisory Committee on 
Immunization Practices (ACIP). This meeting is open to the public, 
limited only by room seating. The meeting room accommodates 216 for 
public seating. Rooms 245, 246, and 247, adjacent to the meeting room, 
will be available once the meeting room reaches capacity, providing up 
to 120 additional seats. Time will be available for public comment. The 
meeting will be webcast live via the World Wide Web; for instructions 
and more information on ACIP please visit the ACIP website: http://www.cdc.gov/vaccines/acip/index.html. Written public comments submitted 
by 72 hours prior to the ACIP meeting will be provided to the ACIP 
members before the meeting.

Public Participation

    Interested persons or organizations are invited to participate by 
submitting written views, recommendations, and data. Please note that 
comments received, including attachments and other supporting 
materials, are part of the public record and are subject to public 
disclosure. Comments will be posted on https://www.regulations.gov. 
Therefore, do not include any information in your comment or supporting 
materials that you consider confidential or inappropriate for public 
disclosure. If you include your name, contact information, or other 
information that identifies you in the body of your comments, that 
information will be on public display. CDC will review all submissions 
and may choose to redact, or withhold, submissions containing private 
or proprietary information such as Social Security numbers, medical 
information, inappropriate language, or duplicate/near duplicate 
examples of a mass-mail campaign. CDC will carefully review and 
consider all comments submitted to the docket.

Matters To Be Considered

    The agenda will include discussions on human papillomavirus 
vaccines, pneumococcal vaccines, Japanese encephalitis vaccines, 
influenza vaccines, anthrax vaccine, hepatitis vaccines, Pertussis 
vaccine, herpes zoster vaccine, and meningococcal vaccines. A 
recommendation vote is scheduled for anthrax vaccine and Japanese 
encephalitis vaccines. Agenda items are subject to change as priorities 
dictate. For more information on the meeting agenda visit https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

    Dated: January 30, 2019.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-01958 Filed 2-11-19; 8:45 am]
 BILLING CODE 4163-18-P